Professional Documents
Culture Documents
Here let's illustrate the theory and show the numerical example of making cash flow projections
for impairment tests.
Please be warned that there are many variations of the cash flow projections and value in use
calculations, and you should always apply your judgment (while following the rules).
The impairment testing aims at proving that the carrying amount of an asset or cash-generating
unit is LOWER than its recoverable amount .
Recoverable amount is the higher of fair value less costs of disposal and value in use.
We always know the carrying amount – please look to your financial statements or accounting
records.
However, in order to determine the recoverable amount, we need to find out either fair value less
costs of disposal or value in use.
It is possible to determine the asset's fair value less cost of disposal AND it is greater than
the asset's carrying amount. In this case, you don't have to calculate value in use, because
the asset is not impaired; or
The asset generates anonymously identifiable and independent cash inflows.
Based on my own experience, the vast majority of companies perform impairment tests on cash-
generating units, because it is hard to determine fair value of used assets and the assets generate
independent cash inflows rarely on its own.
Special For You! Have you already checked out the IFRS Kit ? It's a full IFRS learning
package with more than 40 hours of private video tutorials, more than 140 IFRS case studies
solved in Excel, more than 180 pages of handouts and many bonuses included. If you take action
today and subscribe to the IFRS Kit, you'll get it at discount! Click here to check it out!
For this reason, this example will show you how to draft the cash flow projections for value in
use calculation on cash-generating unit (CGU), not on an individual asset.
The carrying amount of a subsidiary, including allocated goodwill and working capital (current
assets and current liabilities), is CU 150 000.
It is not possible to determine its fair value less costs of disposal and therefore the parent
determines the subsidiary's recoverable amount based on its value in use.
For the purpose of value in use calculation, the parent makes the following assumptions:
Based on information about the subsidiary's industry, the market expects the growth of
5% per year in average for the next 5 years, and then 2% in the long term. These rates are
nominal and include the effect of inflation.
Pre-tax discount rate determined based on company's cost of capital is 8% pa
Based on past experience, the company assumes the annual replacement capital
expenditure of CU 500 per year net of the inflation effect.
Fixed are the same in real terms (hint: careful about the inflation costs!). They exclude
depreciation and amortization.
Variable are about 30% of the revenue.
The assumed inflation rate is 1.5% pa for the next 10 years.
Our starting point is to prepare the forecast of CGU's profits – not yet cash flows.
Based on the numbers and assumptions above, we can calculate the net profits as follows:
Notes:
Revenue in the year 20X2 was calculated as revenue in 20X1 of CU 50 000 increased by
the growth rate of 5%: 50 000*(1+5%) = 52 500. Revenues in the next years were
calculated accordingly.
Fixed costs were increased by the inflation rate of 1.5% each year. For the year 20X2:
CU 25 000*(1+1.5%) = 25 375
Variable are simply 30% of revenue costs
EBIDTA = earnings before interest, depreciation, tax and amortization
Now, you might ask: Why did we stop at profit before tax, depreciation, interest and
amortization?
Not yet.
With regard to changes in working capital, you need to forecast the net balance of your working
capital at the end of each period and then adjust EBIDTA.
For example, if opening net balance of your working capital in 20X2 is CU 1 000 (net assets)
and closing balance of your working capital in 20X2 is CU 1 100, then the cash flow change in
net working capital is CU -100.
The logic is simple: you have more money tied up in a working capital at the end of 20X2 than in
the beginning of 20X2, thus the net cash flow change is negative as you have less cash available
(CU 1 000-CU 1 100).
Opening and closing net working capital numbers are forecasted, in other words – I made
them up in this example.
Capex is assumed annual 500 increased by the inflation rate.
In many cases, companies use their own cost of capital derived by WACC model , which is often
OK for auditors, too.
However, be careful, because WACC will give you post-tax rate and you are required to use pre-
tax rate here.
You can make an attempt to calculate value in use based on post-tax rate, but in such a case your
cash flows need to incorporate tax effects – and that is not a very nice, neat and reliable exercise.
I strongly recommend calculating pre-tax rate from your post-tax rate (eg WACC) – here's an
article that can help .
However, let me add here, that this formula does not always work well. In other words, pre-tax
rate is not always the post-tax rate grossed up by the appropriate tax rate.
But let's not get into many details here, because that's the topic for another article.
You need to make a good assumption when most of your cash flows happen .
In the beginning of the year? At the end of the year? Or are they spread evenly throughout the
year?
If they are spread evenly, then you should apply so-called “mid-year convention” in calculating
your discount factors.
For example, let's say that you want to discount cash flows in the year 2 and you assume they are
spread evenly throughout the year 2.
Thus you will use the number 1.5 as number of years in the discount factor formula. It indicates,
that the cash flows happen in the middle of the year 2.
In the following table, I use the year-end convention . For example, in the year 2, I use number 2
as number of years in the discount factor formula:
Notes:
Discount factor for the year 20X3 (year 2) = 1/((1+8%) to the power of 2)
Present value of cash flows in the year 1 = net cash flows in the year 1 of 10 768
multiplied with the discount factor for the year 1
Net present value = sum of all present values of cash flows in individual years
However, in this particular case we can reasonably assume that a subsidiary – our CGU in testing
– will operate its business for an indefinite number of years.
Therefore the terminal value estimates the net cash flows beyond forecasted period .
1. Exit multiple – this is the multiple of shareholders' cash flows in the last year of
projections.
In our example, we assume to make net cash inflow of 17 032 CU at the end of year 5 in
your projections.Market data says that similar companies sell for multiple of 10 meaning
that to sell your company you can ask ten times your net shareholders ' cash flow.
In this case, you can estimate your terminal value to be 10 x 17 032 = 170 320.
Then you need to discount it with the pre-tax discount rate: 170 320 * 0.681 = 115 988
and include in the cash flow projections.
2. Perpetuity – you will take the last year's projection and apply perpetuity formula to it.
In this example, we project the net cash inflow of 17 032 CU at the end of year 5.We
assume the long-term growth rate to be 2% and your pre-tax discount rate is 8%.Then we
can apply the growing perpetuity formula which is the cash flow after the first period
divided by the difference between the discount rate and the growth rate.
In fact you are calculating growing perpetuity as a series of periodic payments that grow
at a proportionate rate for an infinite amount of time.So, your terminal value would be:
o CU 17 032, being the net cash flow in the last year (year 5) – just note that here it
is unadjusted, but you should adjust it for terminal value calculation if needed;
o Increased by the annual rate of 2%: CU 17 032*(1+2%)= 17 373;
o Divided by the difference between the discount rate of 8% and growth rate of 2%
= 17 373/(8%-2%) = 289 550;
o Discounted to present value, because you calculate this at the end of year 5 = 289
550 * 0.681= 197 184
As you can see, the two amounts are different when we use different methods:
This is quite normal, because perpetuity method assumes to carry on with business and accept
business risks beyond 5 years, and exit multiple method assumes selling the business and getting
rid of all associated business risks.
However, when the plan is to continue the business indefinitely, then perpetuity method is more
acceptable.
You can now see why you should get the terminal value right: it represents 78% of value in use.
The carrying amount of CGU was CU 150 000. Value in use is CU 251 391, which is much
greater than the carrying amount and thus there's no impairment.
Final words
Please – if you calculate your value in use very close to the carrying amount, then expect that
your auditor will ask a lot of questions and examine your calculations thoroughly.
The reason is that in such a sensitive case , even a slight shift in your assumptions can bring you
from “no impairment” to “impairment loss like a hell”.
Did you like this article or do you have any questions? Please leave me a comment below.
Thanks!